Amneal Pharmaceuticals (AMRX) Receivables - Other (2017 - 2026)
Amneal Pharmaceuticals (AMRX) recorded Receivables - Other of $4.6 million in Q2 2026, down 71.8% from $16.33 million a year earlier and down 25.4% from the prior quarter.
Powered by 
Analysis
Amneal Pharmaceuticals (AMRX) Receivables - Other (2017 - 2026) Analysis & Trends
At the end of FY2025, Amneal Pharmaceuticals reported Receivables - Other of $5.3 million, up 18.6% from FY2024.
- Annual Receivables - Other has a five-year compound annual growth rate of -20.9% (FY2020 to FY2025).
- Across earlier years, Receivables - Other came in at $4.47 million in FY2024 (-55.0%), $9.93 million in FY2023 (-70.0%), $33.13 million in FY2022 (+239.1%) and $9.77 million in FY2021 (-42.9%).
- The Q2 2026 figure is the lowest quarterly Receivables - Other since Q4 2024.
- On a year-over-year basis, Receivables - Other rose in four of the last eight quarters, with growth averaging 3.7%.
- Peak year-over-year performance for Receivables - Other in the last five years was growth of 209.9% in Q3 2021, against a decline of 90.0% in Q4 2021 at the low end.
- Per Business Quant, the preceding three quarters came in at $6.17 million (Q1 2026), $5.3 million (Q4 2025) and $14.84 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,147.40 Bn | 1,115.99 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 623.11 Bn | 541.63 Bn | 17.26 Bn |
| 3 | AbbVie | 509.31 Bn | 482.42 Bn | 12.70 Bn |
| 4 | Merck | 365.84 Bn | 320.22 Bn | 12.21 Bn |
| 5 | Novartis Ag | 297.69 Bn | 261.68 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.62 Bn | 235.30 Bn | 12.86 Bn |
| 7 | Amgen | 235.65 Bn | 191.05 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 194.07 Bn | 168.27 Bn | 6.22 Bn |
| 9 | Pfizer | 171.97 Bn | 118.61 Bn | 10.94 Bn |
| 10 | Amneal Pharmaceuticals | 6.33 Bn | 5.52 Bn | 334.51 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.60 Mn |
| Mar 31, 2026 | 6.17 Mn |
| Dec 31, 2025 | 5.30 Mn |
| Sep 30, 2025 | 14.84 Mn |
| Jun 30, 2025 | 16.33 Mn |
| Mar 31, 2025 | 20.51 Mn |
| Dec 31, 2024 | 4.47 Mn |
| Sep 30, 2024 | 7.86 Mn |
| Jun 30, 2024 | 7.89 Mn |
| Mar 31, 2024 | 12.80 Mn |
| Dec 31, 2023 | 9.93 Mn |
| Sep 30, 2023 | 15.11 Mn |
| Jun 30, 2023 | 14.47 Mn |
| Mar 31, 2023 | 14.02 Mn |
| Dec 31, 2022 | 33.13 Mn |
| Sep 30, 2022 | 9.37 Mn |
| Jun 30, 2022 | 17.75 Mn |
| Mar 31, 2022 | 47.21 Mn |
| Dec 31, 2021 | 100,000.00 |
| Sep 30, 2021 | 45.30 Mn |
API Access
Amneal Pharmaceuticals Receivables - Other API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-other&ticker=AMRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-other", "ticker": "AMRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables-other&ticker=AMRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();